Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies-Reference-Cited by-同舟云学术

Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies

Published:2015-05 Issue:5 Volume:21 Page:906-912
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Alousi Amin M.,Brammer Jonathan E.,Saliba Rima M.,Andersson Borje,Popat Uday,Hosing Chitra,Jones Roy,Shpall Elizabeth J.,Khouri Issa,Qazilbash Muzaffar^ORCID,Nieto Yago,Shah Nina,Ahmed Sairah,Oran Betul,Al Atrash Gheath,Ciurea Stefan,Kebriaei Partow,Chen Julianne,Rondon Gabriela,Champlin Richard E.

Funder

Otsuka America Research, Inc

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference24 articles.

1. Graft-versus-host disease: state of the science;Alousi;Biol Blood Marrow Transplant,2013

2. Blocking both signal 1 and signal 2 of T cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance;Li;Nat Med,1999

3. Characterization of the autoreactive T cell repertoire in cyclosporin-induced syngeneic graft-versus-host disease. A highly conserved repertoire mediates autoaggression;Fischer;J Immunol,1995

4. Transfer of cyclosporine-associated syngeneic graft-versus-host disease by thymocytes. Resemblance to chronic graft-versus-host disease;Beschorner;Transplantation,1988

5. Effects of cyclosporine A on T cell development and clonal deletion;Jenkins;Science,1988

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-transplantation cyclophosphamide as GVHD prophylaxis in allogenic hematopoietic stem cell transplantation: Recent advances and modification;Blood Reviews;2023-11

2. Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir;Bone Marrow Transplantation;2023-07-19

3. Prospective Study of a Modified Post-Transplantation Cyclophosphamide Regimen for Severe Aplastic Anemia Patients with HLA-Haploidentical Transplantation;Transplantation and Cellular Therapy;2023-07

4. Post‐transplant cyclophosphamide as sole GHVD prophylaxis after matched reduced‐intensity conditioning allotransplant;Clinical and Translational Medicine;2023-04

5. Should anti-thymocyte globulin be added in post-transplant cyclophosphamide based matched unrelated donor peripheral blood stem cell transplantation for acute myeloid leukemia? A study on behalf of the Acute Leukemia Working Party of the EBMT;Bone Marrow Transplantation;2022-09-07